News

How Hims Became the King of Knockoff Weight-Loss Drugs
Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...
Market on Mute? Not for These 10 Stocks With Surprising Gains
Wall Street’s main indices finished in the green but with lackluster gains, with the Nasdaq rising 0.27 percent, the S&P 500 ...
The unlikely pact and breakup of a drugmaker and a telehealth star
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...
Hims CEO reveals details of Novo Nordisk partnership breakdown - WaPo
Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...